about
Efficacious gene silencing in serum and significant apoptotic activity induction by survivin downregulation mediated by new cationic gemini tocopheryl lipids.New dimeric carbazole-benzimidazole mixed ligands for the stabilization of human telomeric G-quadruplex DNA and as telomerase inhibitors. A remarkable influence of the spacer.Efficacious redox-responsive gene delivery in serum by ferrocenylated monomeric and dimeric cationic cholesterols.α-Tocopherol derived lipid dimers as efficient gene transfection agents. Mechanistic insights into lipoplex internalization and therapeutic induction of apoptotic activity.Design and synthesis of new benzimidazole-carbazole conjugates for the stabilization of human telomeric DNA, telomerase inhibition, and their selective action on cancer cells.Efficacious anticancer drug delivery mediated by a pH-sensitive self-assembly of a conserved tripeptide derived from tyrosine kinase NGF receptor.Efficient Cellular Knockdown Mediated by siRNA Nanovectors of Gemini Cationic Lipids Having Delocalizable Headgroups and Oligo-Oxyethylene Spacers.Efficacious cellular codelivery of doxorubicin and EGFP siRNA mediated by the composition of PLGA and PEI protected gold nanoparticles.Reduction Responsive Nanovesicles Derived from Novel α-Tocopheryl-Lipoic Acid Conjugates for Efficacious Drug Delivery to Sensitive and Drug Resistant Cancer Cells.New pH-responsive gemini lipid derived co-liposomes for efficacious doxorubicin delivery to drug resistant cancer cells.Exclusive detection of sub-nanomolar levels of palladium(II) in water: an excellent probe for multiple applicationsAn efficient synthesis and biological evaluation of novel analogues of natural product Cephalandole A: A new class of antimicrobial and antiplatelet agentsEfficacious Doxorubicin Delivery Using Glutathione-Responsive Hollow Non-phospholipid Vesicles Bearing Lipoyl Cholesterols
P50
Q35464095-F15E8713-E10B-41B9-8367-2A833FCC9691Q38856151-B2266786-BDB8-4BFD-BD2A-AF78069FC745Q38900945-CA581B6D-7B18-4B43-A2A6-F4691CA2DCEFQ38922635-13AFA73C-D2A2-41D4-A28E-CF9D595996ACQ38971739-A7531E2D-CE7C-45C9-A923-6A47A1A4B6CAQ39043167-4762AA15-502D-4C7B-9FFE-97775405013CQ41601152-564835CE-64F4-4211-8F83-95F0C7101576Q47909421-431F356A-659E-4765-BD4C-3E3C3AD8DCBBQ48045710-53A64D71-3945-4F6F-B0CB-C68F24880C89Q53178979-2E807648-219C-4A1D-9716-A90D5E5E83B1Q85280465-DA58D48C-3D0B-493E-AA4A-3CC4745306A2Q89078298-1A77FCAF-9960-4BAA-8492-5767A8FEB270Q92271629-DE59DA52-5FEE-40E6-956F-6DC872F1CBE2
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Krishan Kumar
@ast
Krishan Kumar
@en
Krishan Kumar
@es
Krishan Kumar
@nl
Krishan Kumar
@sl
type
label
Krishan Kumar
@ast
Krishan Kumar
@en
Krishan Kumar
@es
Krishan Kumar
@nl
Krishan Kumar
@sl
prefLabel
Krishan Kumar
@ast
Krishan Kumar
@en
Krishan Kumar
@es
Krishan Kumar
@nl
Krishan Kumar
@sl
P106
P1153
18536327500
P31
P496
0000-0002-0088-3662